| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $570K | +107.3% |
| R&D Expense | $16.6M | +18.6% |
| SG&A Expense | $6.9M | +10.9% |
| Operating Income | -$22.9M | -15.0% |
| Interest Expense | $1K | -50.0% |
| Pre-tax Income | -$20.3M | -2.2% |
| Income Tax | $0 | — |
| Net Income | -$20.3M | -2.2% |
| EPS (Basic) | -$43.68 |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $1.5M | -76.0% |
| Accounts Receivable | $961K | +449.1% |
| Current Assets | $3.3M | -55.2% |
| Total Assets | $3.6M | -54.5% |
| Current Liabilities | $5.9M | +133.2% |
| Long-term Debt | $26K | -74.3% |
| Total Liabilities | $5.9M | +113.4% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$17.2M | +9.6% |
| Capital Expenditures | $67K | -32.3% |
| Investing Cash Flow | -$67K | +32.3% |
| Financing Cash Flow | $12.4M | -26.7% |
| Free Cash Flow | -$17.3M | +9.8% |
| -9193.6% |
| EPS (Diluted) | -$43.68 | -9193.6% |
| Stockholders' Equity |
| -$2.3M |
| -144.5% |